Supernus pharmaceuticals inc

Major-Pharmaceuticals

SUPN


1550 East Gude Drive
Rockville , MD 20850

Executive/
Director

Price

  • Last Close
  • $ 36.87
    $ +0.42 1.17 %
    Jan 3, 2025
  • 52-Week High/Low
  • $35.17 - $22.72
  • YTD
  • 1.8%

  • Trading Volume
  • 4,673
  • Market Cap Full
  • $ 2B
  • Shares Outstanding
  • 54.6M
    Nov 1, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 13.5% 24% 14.9% 5.5% -5% 4.4% 9.3% 1.6% 17.8% 1.8%
Q2 33.6% 37.7% 35.6% -8.7% 4% 17.2% -10.5% -17% -20% -
Q3 21.4% -7.2% -11% -17% 8% -12.6% 17.1% -8.3% 17.4% -
Q4 2.1% -2.6% -32.3% -13.1% 20.7% 9.9% 5.4% 6.7% -0.5% -
J F M A M J J A S O N D
2025 1.8% - - - - - - - - - - -
2024 -4.4% 7.3% 14.8% -13.6% -7.8% -1% 11% 17.4% - - - -1%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    62%88%58%-17%-28%6%18%21%-19%25%2%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.08 0.19 0.49 0.34 0.4 0.11 0.43 0.29
Q2 0.18 0.32 0.57 0.61 0.65 0.43 0.14 -0.02
Q3 0.37 0.29 0.52 0.54 0.74 0.4 0.03 -0.29
Q4 0.26 0.44 0.47 0.61 0.57 0.04 0.44 -
A 0.9 1.2 2.1 2.1 2.4 1 1 -0.02

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 52.3 52.5 52.9 53.4 54.4
Jun 51.8 52.4 52.5 53 53.4 54.5
Sep 52.2 52.4 52.7 53.1 53.5 54.6
Dec 52.3 52.5 52.7 53.2 54.1 54.6

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1 0.9 1.1 0.6 0.6
Fixed Asset Turnover 4.5 3.1 1.2 0.6 1
Total Asset Turnover 0.4 0.3 0.4 0.3 0.4
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -3.1 2.6 3.7 4.1 4.4
Equity multiplier 0.2 0.2 0.6 1 0.9